GRAM publications
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet, 404, 1199 - 1226
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators None., (2022), Lancet, 399, 629 - 655
Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
GRAM Typhoid Collaborators None., (2024), Lancet Glob Health, 12, e406 - e418
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators None., (2024), Lancet Glob Health, 12, e201 - e216
The burden of antimicrobial resistance in the Americas in 2019: a cross-country systematic analysis.
Antimicrobial Resistance Collaborators None., (2023), Lancet Reg Health Am, 25
Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Antimicrobial Resistance Collaborators None., (2022), Lancet, 400, 2221 - 2248
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators None., (2022), Lancet Public Health, 7, e897 - e913
Mapping local variation in household overcrowding across Africa from 2000 to 2018: a modelling study.
Chipeta MG. et al, (2022), Lancet Planet Health, 6, e670 - e681
Global antibiotic consumption and usage in humans, 2000-18: a spatial modelling study.
Browne AJ. et al, (2021), Lancet Planet Health
The challenges of estimating the human global burden of disease of antimicrobial resistant bacteria.
Dunachie SJ. et al, (2020), Curr Opin Microbiol, 57, 95 - 101
Recent publications by Researchers affiliated with the GRAM project
Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study.
Waterlow NR. et al, (2024), PLoS Med, 21
The burden and dynamics of hospital-acquired SARS-CoV-2 in England.
Cooper BS. et al, (2023), Nature
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance.
Cavany S. et al, (2023), Nat Commun, 14
Attributable Mortality and Excess Length of Stay associated with Third-Generation Cephalosporin Resistant Enterobacterales Bloodstream Infections – a prospective cohort study in Suva, Fiji
Loftus MJ. et al, (2022), Journal of Global Antimicrobial Resistance
The potential impact of intensified community hand hygiene interventions on respiratory tract infections: a modelling study.
Pham TM. et al, (2022), Proc Math Phys Eng Sci, 478
Populations of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae are different in human-polluted environment and food items: a multicentre European study
Martak D. et al, (2022), Clinical Microbiology and Infection, 28, 447.e7 - 447.e14
Effect of Delays in Concordant Antibiotic Treatment on Mortality in Patients With Hospital-Acquired Acinetobacter Species Bacteremia: Emulating a Target Randomized Trial With a 13-Year Retrospective Cohort
Lim C. et al, (2021), AMERICAN JOURNAL OF EPIDEMIOLOGY, 190, 2395 - 2404
Probabilistic modelling of effects of antibiotics and calendar time on transmission of healthcare-associated infection.
Laager M. et al, (2021), Sci Rep, 11
Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
Mo Y. et al, (2021), PLoS Med, 18
Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patients.
Riccio ME. et al, (2021), Clin Microbiol Infect, 27, 1322 - 1329